Aspirin for primary prevention of ST segment elevation myocardial infarction in persons with diabetes and multiple risk factors

BACKGROUND: Controversy exists as to whether low-dose aspirin use may give benefit in primary prevention of cardiovascular (CV) events. We hypothesized that the benefits of aspirin are underevaluated. METHODS: We investigated 12,123 Caucasian patients presenting to hospital with acute coronary syndr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:EClinicalMedicine
Autors principals: Bugiardini, Raffaele, Pavasović, Saša, Yoon, Jinsung, van der Schaar, Mihaela, Kedev, Sasko, Vavlukis, Marija, Vasiljevic, Zorana, Bergami, Maria, Miličić, Davor, Manfrini, Olivia, Cenko, Edina, Badimon, Lina
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2020
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7599315/
https://ncbi.nlm.nih.gov/pubmed/33150322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2020.100548
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars